Ornidyl

Active Ingredient(s): Eflornithine
FDA Approved: * November 28, 1990
Pharm Company: * SANOFI AVENTIS US
Category: Women's Health / Fertility

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ornidyl Overview

Eflornithine, sold under the brand name Vaniqa among others, is a medication used to treat African trypanosomiasis (sleeping sickness) and excessive hair growth on the face in women.[1][2] Specifically it is used for the 2nd stage of sleeping sickness caused by T. b. gambiense and may be used with nifurtimox.[1][3] It is used by injection or applied to the skin.[1][2] Common side effects when appli...

Read more Ornidyl Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Eflornithine

Recent Ornidyl Forums: RSS Feed

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Eflornithine
  • Cream: 13.9%, 13.90%
  • Injection: 200mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Eflornithine or a similar ingredient: (2 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA